UAE Cancer Diagnostics Market to Grow with Impressive CAGR until 2027

UAE Cancer Diagnostics Market is anticipated to grow with increasing investments in the healthcare advancements, in the forecast period, 2023-2027F.

According to TechSci report on, “UAE Cancer Diagnostics Market - By Region, Competition Forecast & Opportunities, 2027”, UAE cancer diagnostics market might register an impressive CAGR during the forecast period, 2023-2027, to establish growth due to factors like increasing demands for the early and efficient diagnostic processes for the early diagnosis of cancer cases. Increasing instances of cancer and rapidly increasing new cases every year in the country is further during the growth of the UAE cancer diagnostics market in the upcoming five years.

Higher prevalence of smoking and drinking among the younger population along with the increasing carcinogenic toxins in the environment due to increasing industrialization is increasing the cancer risks thereby supporting the growth of the UAE cancer diagnostics market in the next five years. Consistent research and technological advancements would further drive the market growth.

For the early and effective diagnosis, it is important to find highly efficient medical devices, instruments, tools, along with the higher efficient kits and reagents that help in identifying the cancer cells present in the patient. Moreover, utilization of biomarkers to diagnose the specific type of cancer and deduce the most effective treatment based on patient’s genomic information, cancer stage, and lethality of the cancer is also a major advancement being considered for the diagnosis and treatment of the cancer.

Similar advancement in method and products would facilitate the growth of the UAE cancer diagnostics market in the future five years. Growing investments in the healthcare industry, through government investments or from foreign direct investment along with private investments support the market growth.

Research, product development, manufacturing of medical devices requires high financial investments. The country also depends on the import of medical devices and attest diagnostic kits thus demanding higher investment along with favorable government schemes & tax incentives, that substantiates the growth of the market indirectly along with the growth of the healthcare industry in the country.

Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on "UAE Cancer Diagnostics Market"

https://www.techsciresearch.com/report/uae-cancer-diagnostics-market/8307.html

The UAE cancer diagnostics market is segmented by product, technology, application, end user, competitional landscape, and regional distribution. Based on product, the market is divided between consumable and instruments. Consumables include antibodies, kits & reagents, probes, and others. Instruments include pathology instruments, imaging instruments, and biopsy instruments.

Instruments are anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years on grounds of higher costs of the medical devices and instrument, utilized for the cancer diagnosis. Surging cases of breast cancer requires mammograms for the diagnosis of the cases and severity of the cancer in patients.

Processes like digital breast tomosynthesis, contrast enhanced mammography, acoustic radiation force impulse, etc. are technologically advanced methods that require respective medical devices and its expert operations. These factors majorly drive the growth of the segment along with the UAE cancer diagnostic market in the next five years.

Technology segment of the market is further segmented into IVD testing, imaging, and biopsy. Imaging is anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years due to expanding radiography applications in oncological diagnostics and treatment.

Utilization of computed tomography (CT Scan), magnetic resonance imaging (MRI), nuclear imaging, orthopedic scans (to identify bone cancer), positron emission tomography (PET Scan), ultrasounds, x-ray scans, account for the increasing dependency over imaging methods of cancer diagnostics thereby driving the growth of the market in the future.

In vitro diagnostic (IVD) testing includes pathological analysis through cytology, surgical pathology, flow cytometry and molecular testing. Biopsy involves surgical removal of cancerous cells from their target site and its observation under microscopic ailments. The process also includes procedures like colonoscopy, bronchoscopy, other than surgical extraction of tumor cells.

By application, the market is bifurcated into breast cancer, lung cancer, colorectal cancer, and others. Breast cancer is anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years due to increasing cases of breast cancer in the recent years. In the year 2020, breast cancer held largest shares of the new cancer cases, about 21.4% amounting to 1030 cases out of the total 4807 new cancer cases discovered in the year.

Based on end user, the market is fragmented into hospitals & clinics, diagnostic laboratories, and others. Hospital & clinics are expected to dominate the market segment due to increasing patient count every year. Availability of the in-expensive medical devices, and advanced diagnostic test kits further facilitate the growth of the segment. Diagnostic laboratories are rapidly gaining growth due to increasing patient burden on the hospitals and clinics. Increasing investments in the healthcare infrastructure also aid market growth.

A partial list of major market players of the UAE cancer diagnostics market includes:

·         GE Healthcare FZE

·         Abbott Laboratories S A

·         Roche Diagnostics Middle East FZCO

·         FUJIFILM Middle East FZE

·         Danaher Middle East LLC

·         Agilent Technologies UAE

·         Hologic Inc. UAE

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=8307

Customers can also request for 10% free customization on this report.

“Dubai region is anticipated to lead the regional analysis of the market in the upcoming five years due to increasing number of diagnostic labs in the region. Increasing number of oncologists, and cancer diagnostic experts also aid to the increasing number of personal clinics of the oncologists. Government funds to provide the medical instruments and diagnostic kits & reagents would also aid the market growth,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“UAE Cancer Diagnostics Market By Product (Consumable {Antibodies, Kits & Reagents, Probes, Others} v/s Instruments {Pathology Instruments, Imaging Instruments, Biopsy Instruments}), By Technology (IVD Testing, Imaging, Biopsy), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region, Competition Forecast & Opportunities, 2027” has evaluated the future growth potential of UAE cancer diagnostics market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in UAE cancer diagnostics market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com/